Salisbury Foundation Trust


Internal Reference Number: FOI_5412

Date Request Received: 26/11/2019 09:38:10

Date Request Replied To: 23/12/2019 11:18:16

This response was sent via: By Email

Request Summary: Number of patients treated with Drugs

Request Category: Companies

Question Number 1:
Please detail the number of patients treated by your Trust with the stated therapies, regardless of tumour type, during the time period January 2019 to June 2019 inclusive.

Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Ipilimumab (Yervoy)
Dabrafenib (Tafinlar)
Cabozantinib (Cabometyx)
Sunitinib (Sutent)
Pazopanib (Votrient)
Axitinib (Inlyta)
Atezolizumab (Tecentriq)
Sorafenib (Nexavar)
Tivozanib (Fotivda)
Lenvatinib (Lenvima)
Cetuximab (Erbitux)
Everolimus (Afinitor)
Vemurafenib (Zelboraf)
Answer To Question 1:
Pembrolizumab (Keytruda) 8
Nivolumab (Opdivo) <5
Ipilimumab (Yervoy) 0
Dabrafenib (Tafinlar) 0
Cabozantinib (Cabometyx) 0
Sunitinib (Sutent) <5
Pazopanib (Votrient) 0
Axitinib (Inlyta) 0
Atezolizumab (Tecentriq) 7
Sorafenib (Nexavar) <5
Tivozanib (Fotivda) 0
Lenvatinib (Lenvima) 0
Cetuximab (Erbitux) <5
Everolimus (Afinitor) <5
Vemurafenib (Zelboraf) 0
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E:
© 2021 Salisbury NHS Foundation Trust
Trust Values